In the early stages, fatty liver may be asymptomatic, with most people unaware they have it. However, continued fat buildup ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...

NASH diagnostics consists of CK-18 total, CK-18 cleaved, adiponectin and resistin. NASH diagnostic panel consists of diabetes, gender, BMI, triglyceride and CK-18 total, CK-18 cleaved levels.

Roche’s Genentech unit bought Jecure Therapeutics and its portfolio of NLRP3 drugs in 2018, focusing on peripheral drugs for NASH, liver fibrosis, gout, inflammatory bowel disease, and ...

Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease worldwide affecting approximatively 20–30% ...

Our results highlight the utility of a new panel of biochemical markers (ST) for the prediction of steatosis of different origins. A cut-off of 0.30 had 90% sensibility and a cut-off of 0.72 had ...

The presence and progression of liver fibrosis led by hepatic inflammation is the main predictor of liver ... As a result, it was found that ultrasoundbased liver steatosis of herbal medicine group ...

Soon-to-be medical school graduates received 877 more primary care position offers in the 2025 Main Residency Match compared with the previous year, according to the National Resident Matching ...